MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 25.745

Change

-0.35 (-1.35)%

Market Cap

N/A

Volume

600.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+2.53 (+4.43%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

+3.56 (+1.69%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.69 (+1.22%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

+1.01 (+0.85%)

USD 19.56B
CGABL The Carlyle Group Inc. 4.625% ..

-0.01 (-0.05%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+3.98 (+6.16%)

USD 5.86B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

+1.72 (+6.10%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

+1.40 (+5.54%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

+0.60 (+0.85%)

USD 2.29B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.47% 15% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.47% 15% F 35% F
Trailing 12 Months  
Capital Gain -8.45% 18% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.45% 17% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.27% 43% F 39% F
Dividend Return 0.27% 36% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.78% 91% A- 98% N/A
Risk Adjusted Return 9.81% 38% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector